A Clinical Study to Evaluate the Safety and Tolerability of BioPB-01 in Healthy Adults - Trial NCT05839444
Access comprehensive clinical trial information for NCT05839444 through Pure Global AI's free database. This phase not specified trial is sponsored by Vedic Lifesciences Pvt. Ltd. and is currently Recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 64 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Vedic Lifesciences Pvt. Ltd.
Timeline & Enrollment
N/A
Apr 27, 2023
Sep 10, 2023
Primary Outcome
To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on,To evaluate the safety of 21 days of BioPB-01 administration on
Summary
The present study is a randomized, placebo-controlled, parallel-group, double-blind clinical
 study. Seventy-eight individuals will be screened, and considering a screening failure rate
 of 20%, approximately 64 participants will be randomized in a ratio of 1:1 to receive either
 BioPB-01 or Placebo
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05839444
Non-Device Trial